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ABSTRACT
Sonneratia, a genus of mangroves from family Lythraceae, is reported for number 
of high biological activity including antimicrobial. Sonneratia ovata Backer is one 
of the species which traditionally used by Indonesian people for the treatment of 
some diseases. In this research, the investigation about biological activity of S. 
ovata Backer as anti-microbial has been performed. The methanol extract of S. 
ovata Backer is highly potential as antimicrobial against gram positive bacteria, S. 
aureus, with IC50 value of 7.7 μg/ml which is higher than of Ampicillin as positive 
control with IC50 value of 37.8 μg/ml. Furthermore, stigmasterol one of the major 
compound of S. ovata Backer has been isolated from the methanol extract of the 
stem bark of S. ovata Backer. Therefore, S. ovata Backer is proven to have high 
activity as antimicrobial, and highly potential to be a new source of antimicrobial 
agent. 
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1. Introduction
Pathogenic microbes are one of the causes of number 
of disease in human, animals, or plants (Purnomo et 
al. 2018). Pathogenic microbes are consist of some 
kinds of microorganisms, such as bacteria, fungus, and 
algae. Some diseases caused by pathogenic microbes, 
specially bacteria are skin infection, pneumonia, 
endocarditis, and osteomilietis that caused by gram 
positive bacteria (Bush and Perez 2017). Because of the 
large number of newly discovered pathogens in last 
period, as well as the increasingly strong resistance 
of pathogens to antibiotics which brings pathogens 
become immune to some well-known antimicrobials 
(Putri et al. 2018; Auwaliyah et al. 2019; Ramadhania 
et al. 2019), therefore, many new antimicrobials are 
needed to inhibit the pathogens growth (Rahman et 
al. 2005).
Sonneratia (Lythraceae) is one of the genus of 
mangroves which only exist in Indomalayan area. 
Sonneratia consists of some species, such as S. 
caseolaris, S. alba, S. apetala, S. griffithi, S. hainanensis, 
S. lanceolata, and S. ovata (Mao and Foong 2013). Its 
high ability to adapt in extreme environment with 
high temperature and salinity, strong wind, and 
muddy anaerobic soil makes Sonneratia become rich of 
secondary metabolites with unique biological activity 
and high of medical potential. Traditionally, Sonneratia 
has been used in treatment of some diseases, such as 
asthma, hepatitis, hemorrage, ulcer, and hemmoroid 
(Bandaranayake 2003). Some reports showed some 
medical potential of Sonneratia, such as S. caseolaris 
has strong antioxidant activity (Bunyapraphatsara 
2003), while Saad et al. 2012 reported that S. alba 
has positive antimicrobial activity against some 
microorganisms (Saad et al. 2012). S. griffithi shows 
a high activity as antihyperglycemia (Tiwari et al. 
2008), and S. caseolaris shows intestinal α–glucosidase 
inhibitory activity (Kaewpiboon et al. 2012). One of the 
species of Sonneratia grows naturally in Indonesian 
coastline, specially in Aru Island, Maluku is S. ovata 
Backer. Morphology of the tree of S. ovata Backer is 
a columnar tree with quadrangular branches high of 
7.2 meters, pale brown to grey color, thin and sharp 
pneumatophores. The leaves are apex obtuse but 
rounded at the base, glossy on the upper surface but 
satiny lower surface. The fruits of S. ovata Backer are 
berry-like with seeds and sized 4-6 cm (Goutham-
Bharathi et al. 2012).
Research about bioactivity of S. ovata Backer have 
been reported (Khumaidah et al. 2018). There are 
several compounds have been successfully isolated 
from the extract of S. ovata Backer and examined for 
the activity. Four compounds were isolated by Nguyen 
et al. 2015. There are three new fenolic compounds; 
sonnerfenolic A, sonnerfenolic B, and sonnerfenolic 
C, and one cerebroside called sonnercerebroside. 
Sonnercerebroside showed high cytotoxic activity 
against MCF-7 cancer cell with IC50 value of 112.8±9.4 
μm (Nguyen et al. 2015).
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S. ovata Backer, which traditionally called 
Manggustang Pante, has been used as a folk medicine 
to treat diseases for over decades by drink the water 
extract of S. ovata Backer. That ethnobotanical report 
indicates that S. ovata Backer has high biological activity 
which can lead to further investigation, specially for 
the antimicrobial activity. 
2. Materials and Methods
2.1. Extraction
The stem bark of S. ovata Backer was collected from 
Aru Islands, Maluku. The plant was dried and powdered 
to form a 1.5 kg of sample. Extraction was conducted 
by soaking sample in seven liters of methanol within 
three days at room temperature. Solvent then was 
evaporated to give 153 grams of methanol extract.
2.2. Isolation
Crude methanol extract of the stem bark of S. 
ovata Backer then was partitioned with butanol and 
water (1:1). The butanol phase was collected and 
evaporated, then was subjected to the silica gel column 
chromatography. Column chromatography was eluted 
with mixture of n-hexane:ethyl acetate (7:3) to gain 
five fractions. Thin layer chromatography was used to 
combine the fractions with the same profile. Fraction 
with one clear spot on TLC chromatogram then purified 
for NMR examination.
2.3. Bacteria Preparation
The antimicrobial assay using gram positive and 
negative bacteria, S. aureus, B. subtilis, E. coli, and 
P. aeruginosa. The bacteria were obtained from the 
collection of Microorganism Laboratory, Department of 
Chemistry, ITS, then were inoculated in Nutrient Broth 
and incubated for 24, 20, 24, and 21 hours, respectively. 
Each of the bacteria in Nutrient Broth then was diluted 
until final concentration of 1 x 104 CFU/ml.
2.4. Antimicrobial Assay
Antimicrobial assay was done by adapting method 
of Arias et al. 2004 with modification. A 50 μl of each of 
gram positive and negative bacteria with concentration 
of 1 x 104 CFU/ml was added to 5 μl sample in 445 
μl Nutrient Broth. The mixture was then incubated 
for 18 hours at 37°C. The antimicrobial activity then 
calculated on 96 micro-well plate at 630 nm using 
spectrophotometer. Positive and negative controls were 
Ampicillin and DMSO, respectively (Arias et al. 2004).
3. Results
3.1. Isolation of Stigmasterol from S. ovata 
Stem Bark
The methanol extract of the stem bark of S. ovata 
Backer (3 grams) was partitioned with butanol and water 
(1:1), two times. The butanol phase were combined 
and evaporated to yield 0.83 gram of crude butanol 
phase. The crude butanol phase then diluted in ethyl 
acetate and subjected to the column chromatography, 
with n-hexane:ethyl acetate (7:3) as the eluent. The 
fractination using column chromatography to give five 
fractions. The profile of the second fraction (Fraction 
B) was monitored using TLC with cerium sulfate as 
the coloring agent and yielded one clear spot with Rf 
value of 0.58. Furthermore, TLC chromatogram profile of 
fraction B and Stigmasterol which was already identified 
using 1H and 13C-NMR, were examined. For 1H-NMR 
(400 MHz, CDCl3) δ (ppm): 0.91 (s, 3H), 0.98 (s, 3H), 
1.06 (s, 3H), 1.19 (s, 3H), 1.23 (s, 3H), 3.20 (tdd, OH, 
H-3), 4.14 (s, 1H), 4.57 (s, 1H), and 5.24 (m, 1H, H-6) 
and 13C-NMR (400 MHz, CDCl3) δ (ppm): 71.95 (C3), 
129.40 (C5), 121.87 (C6), 29.08 (C16), 140.88 (C22), 
138.47 (C23), 32.04 (C25), and 12.41 (C29).
3.2. Antimicrobial Assay
Screening of inhibition against microbial by extract 
of S. ovata Backer showed a significant data where 
S. ovata Backer strongly inhibits growth of S. aureus 
bacteria and slightly inhibits B. subtilis bacteria. In 
addition, extract of S. ovata Backer is not active against 
E. coli and P. aeruginosa (Table 1). This result indicates 
a high potential activity of S. ovata Backer against S. 
aureus bacteria and lead to the calculation of IC50 value 
presented in Figure 1 and summarized in Table 2. On 
the other side, Stigmasterol as a major compound of S. 
ovata Backer has been previously reported its minimum 
inhibitory concentration against S. aureus and E. coli 
bacteria.
Sample
Extract of S. ovata Backer
Positive control (Ampicillin)
S. aureus
155.43±13.9
109.13±4.83
23.8±11.56
86.91±15.8
B. subtilis
NA2
912.32±1461.9
NA2
136.8±54.9
E. coli P. aeruginosa
Inhibition (%)1 against bacteria of
Table 1. Inhibition rate (%) of extract of S. Ovata Backer
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4. Discussion
The TLC chromatogram profile comparation 
between fraction B of S. ovata Backer and Stigmasterol 
standard shows the same Rf value of 0.58. This result 
shows that the fraction B isolated from S. ovata Backer 
is Stigmasterol, which was already identified using 13C 
NMR (Table 2).  The 13C NMR spectrum showed signals 
on the chemical shift of 140.9, 138.5, 129.4, and 121.9 
ppm as groups of alkene. Signal 71.9 ppm for –C‒OH 
(C-3), 31.7 ppm for –CH‒ (C-25), 29.1 ppm for ‒CH2 (C-
16), and 12.4 ppm for carbon methyl (C-29). From the 
NMR data above and comparation to the previously 
NMR data identified by Nayak et al. 2015 it is clarified 
that the compound is Stigmasterol (Figure 2) (Nayak et 
al. 2015).
Screening of inhibition against microbial by extract 
of S. ovata Backer showed a significant data. Extract 
of S. ovata Backer strongly inhibits growth of S. aureus 
bacteria at 155.43±13.95%, while Ampicillin as the 
positive control only inhibits at 109.13±4.83%. However, 
the inhibition rate of extract S. ovata Backer against B. 
subtilis bacteria is as low as 23.8±11.56% compared to 
Ampicillin which strongly inhibits at 86.91±15.8%. On 
the other side, extract of S. ovata Backer does not inhibit 
the gram negative bacteria at all, both against E. coli 
or P. aeruginosa. This result indicates a high potential 
activity of S. ovata Backer against S. aureus bacteria and 
lead to the calculation of IC50 value. Extract of S. ovata 
Backer shows IC50 value of 7.7 μg/ml and Ampicillin 
shows IC50 value of 37.8 μg/ml. The significant result of 
the inhibitory activity of S. ovata Backer against S. aureus 
reveals the fact that S. ovata Backer has extremely 
stronger activity than the common antibacteria, 
Ampicillin. 
The inhibition of gram positive bacteria, S. aureus 
is estimated to be associated with the increasing 
permeability of bacteria membrane (Greenway and 
Dyke 1979). Commonly, long chain fatty acid inhibit 
gram positive bacteria better than gram negative 
bacteria because of the outer membrane of gram 
negative bacteria (Nieman 1954). Gram negative 
bacteria has the outer membrane that prevents fatty 
acid to reach the inner sitoplasm, while there is no 
outer membrane owned by gram positive bacteria. The 
previous report showed that long chain fatty acids are 
bactericidal for the gram positive bacteria that causing 
lysis of protoplasts which stabilized osmotically, 
leakage of absorbing material and protein, both from 
bacteria and protoplasts, and inhibition in oxygen and 
amino acid uptake (Galbraith et al. 1971).   
Stigmasterol, which as  major compound of S. 
ovata Backer has also been tested previously for its 
inhibitory activity against some bacteria. Bacteria 
Sample
Extract of S. ovata Backer
Positive control (Ampicillin)
S. aureus
  7.7
37.8
NT2
NT2
NA1
10.28
NA1
NT2
1NA: Not active, 2NT: Not tested
B. subtilis E. coli P. aeruginosa
IC50 value (μg/ml) against bacteria of
Table 2. IC50 value of extract of S. ovata Backer
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Figure 1. Antimicrobial activity of S. ovata extract against 
S. aureus
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Figure 2. Chemical structure of Stigmasterol
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used in the assay were both gram prositif and gram 
negative bacteria, S. aureus and E. coli. The minimum 
inhibitory concentration was determined using broth 
dilution method, and the MIC was defined as the 
lowest concentration of the compound inhibiting the 
visible growth of each micro-organism, resulting the 
MIC value of 12.5 and 25 μg/ml for the S. aureus and 
E. coli bacteria, respectively (Yusuf et al. 2018). This 
report showed that Stigmasterol is stongly inhibit both 
gram positive and gram negative bacteria that means 
Stigmasterol is potential as antimicobial agent.
5. Conclusion
Exract of S. ovata Backer has high biological activity 
as antimicrobial agent. The extract of S. ovata Backer is 
highly potential as antimicrobial against gram positive 
bacteria, S. aureus better than Ampicillin. Furthermore, 
a major compound has been isolated from the 
methanolic extract of the stem bark of S. ovata Backer 
and recognized as Stigmasterol. Stigmasterol has also 
performed a high inhibitory activity against S. aureus. 
Therefore, extract of S. ovata Backer is highly potential as 
a new antimicrobial against S. aureus. Further isolation 
from the extract of S. ovata Backer and other biological 
activity assay, both on extract and compounds are 
needed to enrich the reports of S. ovata Backer.  
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